Indian Phosphate Q2 FY26 Results & Concall Highlights: Revenue ₹451 Cr
Published 26 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹167 Cr
H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25. The company expects improvement in both top line and bottom line due to the commissioning of the Labsa and sulfuric acid plants by FY27, leading to better integrated operations and cost efficiencies.
From Indian Phosphate's Q2 FY26 earnings-call transcript · updated 26 Aug 2026.
Price
₹72.4
Market Cap
₹167 Cr
P/E Ratio
7.6
Revenue Rank
Margin Rank
How does Indian Phosphate rank in Chemicals & Petrochemicals?
Compare Indian Phosphate against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
📊 Revenue & Sales Performance
Rank 3- →H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25.
- →EBITA rose by 40% in H1 FY 25-26 compared to the previous year.
- →Fertilizer segment expected to improve due to favorable government subsidy restoration.
- →Chemical segment highly diversified, contributing 90% of revenue; expected continued growth with diversification plans.
- →Tamil Nadu Labsa plant commissioning anticipated in FY 26-27, expected to add significant turnover and revenue.
- →Sulfur price volatility impacts revenue, but higher sulfur prices have boosted revenue from sulfuric acid.
- →Sulfuric acid plant capacity utilization currently around 75%, with aggressive sales plans.
- →Expected commissioning and operationalization of the Kudlar project by Q3 or Q4 FY 26-27, which should positively contribute to revenue.
- →Overall outlook optimistic with both fertilizer and chemical segments projected to perform better than last financial year.
📈 Profitability & Margins
Rank 1- →The company expects improvement in both top line and bottom line due to the commissioning of the Labsa and sulfuric acid plants by FY27, leading to better integrated operations and cost efficiencies.
- →EBITA has shown a 40% jump in H1 of current financial year compared to last year, with margins also improving.
- →Subsidy conditions for fertilizer have become favorable again, positively impacting the fertilizer segment.
- →Integrated operations in Tamil Nadu with in-house sulfuric acid production and power generation will reduce costs and improve profitability.
- →EBITA percentage expected to improve further once new plants are fully operational by the last quarter of FY27.
- →Growth is linked to volatile raw material costs like LAB and sulfur, but management is optimistic due to diversification and government policy support.
- →Corporate guarantee related project expected to be operational by FY27, potentially releasing associated guarantees and reducing contingent liabilities.
🏗️ Capital Expenditure Plans
Yes- →The company is prioritizing the commissioning and operation of its Tamil Nadu Kadlar plant (Labsa plant) in the current financial year, expecting full operations by FY27.
- →After the Kadlar plant is operational, focus will shift to the Dhule fertilizer plant; however, there is currently no set timeline for its commissioning.
- →The Dudule sulfuric acid plant was commissioned recently and is operational, contributing to revenues in H1 of the current financial year.
- →The Dhule plant construction is approximately 60-65% completed, with completion and commissioning expected in the third or fourth quarter of the next financial year (FY27).
- →IPO proceeds have been primarily utilized for the Tamil Nadu project; remaining funds and resources will be allocated to the Dhule plant once the Tamil Nadu project stabilization is achieved.
- →No mention of other significant capital or strategic investments beyond these two major projects.
💰 Fundraising & Capital Structure
No information- →Indian Phosphate Limited has not indicated any current or immediate plans for new debt or long-term borrowings. They are currently utilizing only working capital debt and have zero term loans for their Tamil Nadu plant.
- →The company raised funds through an IPO, which supported the setting up of the Tamil Nadu (Kudlar) plant.
- →There is no explicit mention of any future equity fundraising in the transcript.
- →No indication was given of new debt issuance; external credit rating is under renewal with an expectation of improvement.
- →The management is focusing on completing ongoing projects, like the Labsa plant and fertilizer plant, rather than initiating new fundraising at this time.
📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Indian Phosphate Q2 FY26 results?
H1 FY 25-26 revenue increased by ~15% to ₹451 crores versus ₹385 crores in H1 FY 24-25. The company expects improvement in both top line and bottom line due to the commissioning of the Labsa and sulfuric acid plants by FY27, leading to better integrated operations and cost efficiencies.
What is Indian Phosphate share price analysis?
Indian Phosphate currently shows a below-average growth signal. The stock trades at a P/E of 7.6 with a market cap of ₹167 Cr. Investors should review the full earnings analysis for detailed insights.
Is Indian Phosphate planning capital expenditure?
The company is prioritizing the commissioning and operation of its Tamil Nadu Kadlar plant (Labsa plant) in the current financial year, expecting full operations by FY27.
Keep Indian Phosphate on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.